Starling Oncology STLNW
NASDAQ STLNW
$0.04 -0.01 (-21.32%)
As of: Sep 9, 2026 · 12:49 PM EDT

Starling Oncology (STLNW) EBT Margin Growth (3y) (2024 - 2026)

Analysis

Starling Oncology (STLNW) EBT Margin Growth (3y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Davita 11.90 Bn 11.21 Bn 1.16 Bn 240.00
2 RadNet 5.52 Bn 4.79 Bn 88.08 Mn 82.00
3 Fresenius Medical Care AG 4.79 Bn 4.09 Bn 1.52 Bn 216.00
4 Concentra Group Holdings Parent 4.28 Bn 4.12 Bn 192.10 Mn -38.00
5 Privia Health 2.57 Bn 2.16 Bn - 76.00
6 Pediatrix Medical 2.15 Bn 1.74 Bn - 329.00
7 Progyny 2.12 Bn 1.89 Bn 89.30 Mn 559.00
8 Surgery Partners 1.82 Bn 1.61 Bn 622.10 Mn -367.00
9 U S Physical Therapy 1.17 Bn 1.14 Bn 41.94 Mn -370.00
10 Starling Oncology 4.13 Mn -36.96 Mn 27.17 Mn 1,487.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,487.00
Mar 31, 2026 3,762.00
Dec 31, 2025 1,064.00
Sep 30, 2025 -793.00
Jun 30, 2025 -530.00
Mar 31, 2025 -5,405.00
Dec 31, 2024 1,099.00
Sep 30, 2024 -1,196.00
Jun 30, 2024 -2,370.00
Mar 31, 2024 -1,941.00